Investor Relations Home

Printer Friendly Version Print Page  |E-mail this page E-mail Page  |E-mail Alerts E-mail Alerts  |View contacts IR Contacts

Corporate Profile

About Bio-Reference Laboratories, Inc.
BioReference is the third largest full service clinical diagnostic laboratory in the U.S. providing testing and related services to physician offices, clinics, hospitals, long term care facilities, employers, governmental units and correctional institutions. We offer a comprehensive test list focusing on molecular diagnostics, anatomical pathology, genetics, and women’s health. Moreover, through its GeneDx subsidiary, BioReference has an international presence in more than 50 countries around the world.

Read More »

Recent NewsMore »
DateTitle 
06/05/14BioReference Laboratories, Inc. Reports Record Quarterly Revenues and Patient Volumes for Second Quarter FY2014Printer Friendly Version
05/29/14BioReference Laboratories, Inc. Announces Earnings Date for Second Quarter Fiscal Year 2014Printer Friendly Version
04/16/14Bio-Reference Laboratories, Inc. Announces That Robert Daber, Ph.D. Will Join Company as Director of R&D and Cancer GeneticsPrinter Friendly Version
Stock Quote
BRLI (common stock)
ExchangeNASDAQ GS (US Dollar)
Price$30.40
Change (%) - 0.54 (1.75%)
Volume129,300
Data as of 07/11/14 4:00 p.m. ET
Refresh quote
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Bio-Reference Laboratories, Inc. posts new information to the site. Just enter your e-mail address and click Submit.

Quotes delayed at least 15 minutes. Market data provided by Interactive Data.

Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.